Analysis

What Attys Need To Know About Trump's Opioid Policies

Law360, New York (August 9, 2017, 7:12 PM EDT) -- The Trump administration's first six months have witnessed a flurry of activity targeting the nation's tenacious opioid epidemic, highlighting legal risks for any business that handles narcotic painkillers.

The activity has spanned much of the executive branch, including the White House, the U.S. Department of Justice and the U.S. Food and Drug Administration. Some of the moves have real promise, while others appear largely symbolic or even counterproductive, experts say.

Here's what attorneys need to know going forward:

DOJ Casts Wide Net for Opioid Violations

The DOJ has made headlines with civil and criminal enforcement on the opioid front. Last month,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!